Medigenesis Joins the List of Companies Switching To Microsoft SQL Server 2000

REDMOND, Wash., March 13, 2001 — Months into the development cycle, and with costs for the database tier of its current solution spinning out of control, the medical profiling startup Medigenesis Inc. decided it needed to find a more cost-effective solution that fit both its database needs and business model. That solution was to switch from a Solaris and Oracle combination to Microsoft® SQL Server™
2000 running on Intel-based servers. The company — which quantifies human illnesses, enabling common people to compare themselves with others who
“look the same”
from a medical perspective — needed a database that could scale to huge proportions and could handle up to 500,000 concurrent users, as well as store all content for its site on the database tier of the application.

The switch took less than 30 days, and the Microsoft solution was less than one-third the cost of an Oracle solution, enabling Medigenesis to cut costs for the database tier of its application by more than 66 percent, from $900,000 to under $300,000. Taking full advantage of Microsoft Windows® 2000 Advanced Server and Microsoft SQL Server 2000 Enterprise Edition, Medigenesis now enjoys a high-performance, scalable database, out-of-the-box clustering capabilities, and access to a large and well-trained talent pool, allowing the company to spend less time worrying about systems and more time bringing its capabilities to its customers.

More information about the competitive advantages gained by companies that have switched to Microsoft platform solutions is available at http://www.microsoft.com/sql/switchers/ .

Microsoft SQL Server 2000 is the complete database and analysis offering for rapid delivery of the next generation of scalable e-commerce, line-of-business and data warehousing solutions.

Microsoft and Windows are either registered trademarks or trademarks of Microsoft Corp. in the United States and/or other countries.

The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

Note to editors: If you are interested in viewing additional information on Microsoft, please visit the Microsoft Web page at http://www.microsoft.com/presspass/ on Microsoft’s corporate information pages.

Related Posts